Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC [Phase 2]
Phase 2 trial update for tislelizumab plus bevacizumab and paclitaxel (pc) in untreated EGFR-mutant and high PD-L1 non-squamous non-small ce…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy [Phase 2]
Phase 2 clinical trial evaluating platinum-based chemotherapy plus ramucirumab in advanced non-small cell lung cancer patients who progresse…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) [Phase 3]
This document provides an update on the NEPTUNE Phase 3 trial comparing durvalumab with tremelimumab versus standard-of-care as first-line t…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer [Phase 4]
A Phase 4 clinical trial evaluating penpulimab combined with anlotinib as neoadjuvant therapy for resectable non-small cell lung cancer is o…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors [Phase 2]
Phase 2 clinical trial update evaluating SBRT for oligoprogressive non-small cell lung cancer after first-line immune checkpoint inhibitors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT) [Phase 2]
Phase 2 clinical trial evaluating salvage surgery after downstaging of advanced non-small cell lung cancer by targeted therapy.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive [Phase 2]
Phase IIb trial update for BPI-7711 capsules in non-small cell lung cancer patients with T790M mutation (Phase 2, completed).
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Enhertu (trastuzumab deruxtecan) in HER2-expressing or -mutated non-small cell lung cancer has been terminated with results…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating hypofractionated image-guided radiation therapy for stage II-III non-small cell lung cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for BPI-7711 capsule in EGFR T790M-positive non-small cell lung cancer (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating isatuximab plus cemiplimab in advanced malignancies (prostate cancer and non-small cell lung cancer) has terminat…
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy [Phase 3]
Phase 3 trial comparing KD019 to erlotinib in advanced non-small cell lung cancer after prior therapy was terminated.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Study of XL647 in Subjects With Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for XL647 in non-small-cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib [Phase 2]
Phase 2 study of XL647 in non-small cell lung cancer patients who progressed after initial response to gefitinib or erlotinib has been compl…
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Dose Individualization of Pemetrexed - IMPROVE-II [Phase 4]
Phase 4 trial update on dose individualization of pemetrexed (IMPROVE-II) has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating safety and efficacy of vinorelbine with metronomic administration plus atezolizumab as second-line treatment for st…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Dose Individualization of Pemetrexed - IMPROVE-III [Phase 4]
Phase 4 trial update on dose individualization of pemetrexed (IMPROVE-III) completed.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update of BI 2536 for advanced or metastatic non-small cell lung cancer; results have been posted after completion of…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of DCVAC/LuCa immunotherapy in patients with metastatic non-small cell lung cancer (…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Preoperative Brigatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Fusions. [Phase 2]
Phase 2 clinical trial investigating drug tolerant persister (DTP) to preoperative brigatinib in resectable non-small cell lung cancer with …
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC [Phase 2]
A Phase 2 clinical trial evaluating immunotherapy combined with chemotherapy and anti-angiogenic therapy for operable non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating VX15/2503 in combination with avelumab in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy [Phase 2]
Phase 2 trial evaluating SBRT/LDRT with camrelizumab and apatinib in metastatic non-small cell lung cancer patients previously treated with …
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial update evaluating NKT cell infusion for advanced solid tumors, with indications including non-small cell lung cancer and gas…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52) [Phase 3]
Phase 3 TASUKI-52 trial evaluating ONO-4538 (nivolumab) in non-squamous non-small cell lung cancer has completed with results posted.